Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12

1.

PIK3CA and KRAS mutations in cell free circulating DNA are useful markers for monitoring ovarian clear cell carcinoma.

Morikawa A, Hayashi T, Shimizu N, Kobayashi M, Taniue K, Takahashi A, Tachibana K, Saito M, Kawabata A, Iida Y, Ueda K, Saito M, Yanaihara N, Tanabe H, Yamada K, Takano H, Nureki O, Okamoto A, Akiyama T.

Oncotarget. 2018 Feb 22;9(20):15266-15274. doi: 10.18632/oncotarget.24555. eCollection 2018 Mar 16.

2.

ASBEL-TCF3 complex is required for the tumorigenicity of colorectal cancer cells.

Taniue K, Kurimoto A, Takeda Y, Nagashima T, Okada-Hatakeyama M, Katou Y, Shirahige K, Akiyama T.

Proc Natl Acad Sci U S A. 2016 Oct 21. pii: 201605938. [Epub ahead of print]

3.

Long noncoding RNA UPAT promotes colon tumorigenesis by inhibiting degradation of UHRF1.

Taniue K, Kurimoto A, Sugimasa H, Nasu E, Takeda Y, Iwasaki K, Nagashima T, Okada-Hatakeyama M, Oyama M, Kozuka-Hata H, Hiyoshi M, Kitayama J, Negishi L, Kawasaki Y, Akiyama T.

Proc Natl Acad Sci U S A. 2016 Feb 2;113(5):1273-8. doi: 10.1073/pnas.1500992113. Epub 2016 Jan 14.

4.

Susceptibility to proteases of anti-Tn-antigen MLS128 binding glycoproteins expressed in human colon cancer cells.

Oura F, Yajima Y, Nakata M, Taniue K, Akiyama T, Nakada H, Yamamoto K, Fujita-Yamaguchi Y.

Biosci Trends. 2015 Feb;9(1):49-55. doi: 10.5582/bst.2014.01127.

5.

Heterogeneous nuclear ribonucleoprotein K upregulates the kinetochore complex component NUF2 and promotes the tumorigenicity of colon cancer cells.

Sugimasa H, Taniue K, Kurimoto A, Takeda Y, Kawasaki Y, Akiyama T.

Biochem Biophys Res Commun. 2015 Mar 27;459(1):29-35. doi: 10.1016/j.bbrc.2015.02.043. Epub 2015 Feb 19.

PMID:
25701787
6.

The miR-363-GATA6-Lgr5 pathway is critical for colorectal tumourigenesis.

Tsuji S, Kawasaki Y, Furukawa S, Taniue K, Hayashi T, Okuno M, Hiyoshi M, Kitayama J, Akiyama T.

Nat Commun. 2014;5:3150. doi: 10.1038/ncomms4150. Erratum in: Nat Commun. 2014;5:4025.

PMID:
24452072
7.

PCDH10 is required for the tumorigenicity of glioblastoma cells.

Echizen K, Nakada M, Hayashi T, Sabit H, Furuta T, Nakai M, Koyama-Nasu R, Nishimura Y, Taniue K, Morishita Y, Hirano S, Terai K, Todo T, Ino Y, Mukasa A, Takayanagi S, Ohtani R, Saito N, Akiyama T.

Biochem Biophys Res Commun. 2014 Jan 31;444(1):13-8. doi: 10.1016/j.bbrc.2013.12.138. Epub 2014 Jan 6.

PMID:
24406169
8.

The pleiotrophin-ALK axis is required for tumorigenicity of glioblastoma stem cells.

Koyama-Nasu R, Haruta R, Nasu-Nishimura Y, Taniue K, Katou Y, Shirahige K, Todo T, Ino Y, Mukasa A, Saito N, Matsui M, Takahashi R, Hoshino-Okubo A, Sugano H, Manabe E, Funato K, Akiyama T.

Oncogene. 2014 Apr 24;33(17):2236-44. doi: 10.1038/onc.2013.168. Epub 2013 May 20.

PMID:
23686309
9.

ASBEL, an ANA/BTG3 antisense transcript required for tumorigenicity of ovarian carcinoma.

Yanagida S, Taniue K, Sugimasa H, Nasu E, Takeda Y, Kobayashi M, Yamamoto T, Okamoto A, Akiyama T.

Sci Rep. 2013;3:1305. doi: 10.1038/srep01305.

10.

Identification of a link between Wnt/β-catenin signalling and the cell fusion pathway.

Matsuura K, Jigami T, Taniue K, Morishita Y, Adachi S, Senda T, Nonaka A, Aburatani H, Nakamura T, Akiyama T.

Nat Commun. 2011 Nov 22;2:548. doi: 10.1038/ncomms1551.

PMID:
22109522
11.

A member of the ETS family, EHF, and the ATPase RUVBL1 inhibit p53-mediated apoptosis.

Taniue K, Oda T, Hayashi T, Okuno M, Akiyama T.

EMBO Rep. 2011 Jul 1;12(7):682-9. doi: 10.1038/embor.2011.81.

12.

Sunspot, a link between Wingless signaling and endoreplication in Drosophila.

Taniue K, Nishida A, Hamada F, Sugie A, Oda T, Ui-Tei K, Tabata T, Akiyama T.

Development. 2010 May;137(10):1755-64. doi: 10.1242/dev.042077.

Supplemental Content

Loading ...
Support Center